C59, Wnt Antagonist, Wnt signaling pathway inhibitor
Be the first to review this product! Submit a review
|
(19 Publications)
MW 379.5 Da, Purity >97%. Potent Wnt signaling pathway inhibitor. Inhibits porcupine (PORCN) required for Wnt palmitoylation, secretion, and biological activity. Inhibits Wnt-mediated transcription (IC50 = 74 pM) and cell proliferation. Active in vivo..
View Alternative Names
DHOF, FODH, MG61, MGC29687, POR, PORC, PORCN_HUMAN, Probable protein-cysteine N-palmitoyltransferase porcupine, Protein MG61
- Chemical Structure
Lab
Chemical Structure - C59, Wnt Antagonist, Wnt signaling pathway inhibitor (AB142216)
2D chemical structure image of ab142216, C59, Wnt Antagonist, Wnt signaling pathway inhibitor
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Handling instructions
Need more advice on solubility, usage and handling? Please visit our our product support page for more details.
|
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.
Publications (19)
Recent publications for all applications. Explore the full list and refine your search
ACS sensors 9:4626-4636 PubMed39213612
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 14:3346 PubMed37291092
2023
Applications
Unspecified application
Species
Unspecified reactive species
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 37:e22776 PubMed36688817
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular physiology 238:447-458 PubMed36598878
2023
Applications
Unspecified application
Species
Unspecified reactive species
Development (Cambridge, England) 149: PubMed36305473
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of experimental & clinical cancer research : CR 41:89 PubMed35272688
2022
Applications
Unspecified application
Species
Unspecified reactive species
eLife 10: PubMed34702444
2021
Applications
Unspecified application
Species
Unspecified reactive species
Molecular oncology 15:1835-1848 PubMed33969605
2021
Applications
Unspecified application
Species
Unspecified reactive species
ACS pharmacology & translational science 4:1235-1245 PubMed34151213
2021
Applications
Unspecified application
Species
Unspecified reactive species
Pathobiology : journal of immunopathology, molecul 87:327-337 PubMed33254176
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com